Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Spire2 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPIRE2 mRNA] | CTD | PMID:31150632 | Spire2 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Spire2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPIRE2 mRNA | CTD | PMID:36331819 | Spire2 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Spire2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SPIRE2 mRNA | CTD | PMID:22206623 | Spire2 | Rat | 17beta-estradiol | multiple interactions | ISO | SPIRE2 (Homo sapiens) | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of SPIRE2 mRNA | CTD | PMID:20404318 | Spire2 | Rat | 17beta-estradiol | decreases expression | ISO | SPIRE2 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of SPIRE2 mRNA | CTD | PMID:31614463 | Spire2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Spire2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SPIRE2 mRNA | CTD | PMID:19933214 | Spire2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SPIRE2 mRNA | CTD | PMID:33387578 | Spire2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Spire2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SPIRE2 mRNA | CTD | PMID:21570461 and PMID:26377647 | Spire2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SPIRE2 mRNA | CTD | PMID:22298810 | Spire2 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SPIRE2 mRNA | CTD | PMID:30071829 | Spire2 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Spire2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of SPIRE2 mRNA | CTD | PMID:18648102 | Spire2 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of SPIRE2 mRNA | CTD | PMID:31881176 | Spire2 | Rat | aflatoxin B1 | increases methylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of SPIRE2 gene and Aflatoxin B1 results in increased methylation of SPIRE2 intron | CTD | PMID:27153756 and PMID:30157460 | Spire2 | Rat | Aflatoxin B2 alpha | affects methylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | aflatoxin B2 affects the methylation of SPIRE2 intron | CTD | PMID:30157460 | Spire2 | Rat | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SPIRE2 mRNA | CTD | PMID:20488242 | Spire2 | Rat | aristolochic acid A | increases expression | ISO | SPIRE2 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of SPIRE2 mRNA | CTD | PMID:33212167 | Spire2 | Rat | arsane | affects methylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SPIRE2 gene | CTD | PMID:25304211 | Spire2 | Rat | arsenic atom | affects methylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SPIRE2 gene | CTD | PMID:25304211 | Spire2 | Rat | benzo[a]pyrene | affects methylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SPIRE2 intron and Benzo(a)pyrene affects the methylation of SPIRE2 promoter | CTD | PMID:27901495 and PMID:30157460 | Spire2 | Rat | benzo[e]pyrene | decreases methylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of SPIRE2 intron | CTD | PMID:30157460 | Spire2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SPIRE2 mRNA | CTD | PMID:25181051 | Spire2 | Rat | bisphenol A | increases expression | ISO | Spire2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SPIRE2 mRNA | CTD | PMID:32156529 | Spire2 | Rat | caffeine | affects phosphorylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of SPIRE2 protein | CTD | PMID:35688186 | Spire2 | Rat | chlorpyrifos | increases expression | ISO | Spire2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SPIRE2 mRNA | CTD | PMID:37019170 | Spire2 | Rat | choline | multiple interactions | ISO | Spire2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIRE2 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPIRE2 gene | CTD | PMID:20938992 | Spire2 | Rat | clothianidin | decreases expression | ISO | SPIRE2 (Homo sapiens) | 6480464 | clothianidin results in decreased expression of SPIRE2 mRNA | CTD | PMID:29044138 | Spire2 | Rat | copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA | CTD | PMID:26033743 | Spire2 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SPIRE2 mRNA | CTD | PMID:26033743 | Spire2 | Rat | copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA | CTD | PMID:26033743 | Spire2 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SPIRE2 mRNA | CTD | PMID:26033743 | Spire2 | Rat | coumestrol | decreases expression | ISO | SPIRE2 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of SPIRE2 mRNA | CTD | PMID:19167446 | Spire2 | Rat | crocidolite asbestos | increases expression | ISO | Spire2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of SPIRE2 mRNA | CTD | PMID:29279043 | Spire2 | Rat | cyclosporin A | decreases expression | ISO | SPIRE2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SPIRE2 mRNA | CTD | PMID:25562108 | Spire2 | Rat | cyclosporin A | increases methylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | Cyclosporine results in increased methylation of SPIRE2 promoter | CTD | PMID:27989131 | Spire2 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of SPIRE2 mRNA | CTD | PMID:29391264 | Spire2 | Rat | folic acid | multiple interactions | ISO | Spire2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIRE2 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPIRE2 gene | CTD | PMID:20938992 | Spire2 | Rat | folic acid | decreases expression | ISO | Spire2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SPIRE2 mRNA | CTD | PMID:25629700 | Spire2 | Rat | FR900359 | decreases phosphorylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of SPIRE2 protein | CTD | PMID:37730182 | Spire2 | Rat | inulin | multiple interactions | ISO | Spire2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SPIRE2 mRNA | CTD | PMID:36331819 | Spire2 | Rat | L-methionine | multiple interactions | ISO | Spire2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIRE2 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPIRE2 gene | CTD | PMID:20938992 | Spire2 | Rat | methapyrilene | decreases methylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of SPIRE2 intron | CTD | PMID:30157460 | Spire2 | Rat | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of SPIRE2 mRNA | CTD | PMID:26720608 | Spire2 | Rat | Nor-9-carboxy-delta9-THC | multiple interactions | ISO | SPIRE2 (Homo sapiens) | 6480464 | [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of SPIRE2 gene | CTD | PMID:30521419 | Spire2 | Rat | paracetamol | affects expression | ISO | Spire2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SPIRE2 mRNA | CTD | PMID:17562736 | Spire2 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SPIRE2 mRNA | CTD | PMID:33387578 | Spire2 | Rat | paracetamol | increases expression | ISO | SPIRE2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of SPIRE2 mRNA | CTD | PMID:29067470 | Spire2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Spire2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPIRE2 mRNA more ... | CTD | PMID:36331819 | Spire2 | Rat | quercetin | increases phosphorylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of SPIRE2 protein | CTD | PMID:35688186 | Spire2 | Rat | resveratrol | multiple interactions | ISO | SPIRE2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of SPIRE2 mRNA | CTD | PMID:23557933 | Spire2 | Rat | silicon dioxide | increases expression | ISO | Spire2 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of SPIRE2 mRNA | CTD | PMID:29203145 | Spire2 | Rat | sunitinib | decreases expression | ISO | SPIRE2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SPIRE2 mRNA | CTD | PMID:31533062 | Spire2 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPIRE2 mRNA] | CTD | PMID:31150632 | Spire2 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of SPIRE2 mRNA | CTD | PMID:31150632 | Spire2 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SPIRE2 mRNA | CTD | PMID:23411599 and PMID:34492290 | Spire2 | Rat | titanium dioxide | increases expression | ISO | Spire2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SPIRE2 mRNA | CTD | PMID:29264374 | Spire2 | Rat | titanium dioxide | decreases methylation | ISO | Spire2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SPIRE2 gene | CTD | PMID:35295148 | Spire2 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SPIRE2 mRNA | CTD | PMID:33387578 | Spire2 | Rat | valproic acid | increases methylation | ISO | SPIRE2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SPIRE2 gene | CTD | PMID:29154799 | Spire2 | Rat | valproic acid | increases expression | ISO | Spire2 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of SPIRE2 mRNA | CTD | PMID:21427059 | |